Lumexa Imaging Holdings Inc LMRI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $10.10
- Day Range
- $10.18–10.50
- 52-Week Range
- $6.45–19.45
- Bid/Ask
- $9.22 / $12.94
- Shares Outstanding
- 96.07M
- Market Cap
- $991.49M
- Volume/Avg
- 476,421 / 447,314
Key Statistics
- Price/Earnings (Normalized)
- 52.15
- Price/Sales
- 0.92
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 4,335
- Website
- https://www.lumexaimaging.com
Valuation
|
Metric
|
LMRI
|
|---|---|
Price/Earnings (Normalized) | 52.15 |
Price/Book Value | 1.58 |
Price/Sales | 0.92 |
Price/Cash Flow | 10.05 |
Price/Earnings
LMRI
Financial Strength
|
Metric
|
LMRI
|
|---|---|
Quick Ratio | 1.36 |
Current Ratio | 1.44 |
Interest Coverage | 0.82 |
Quick Ratio
LMRI
Profitability
|
Metric
|
LMRI
|
|---|---|
Return on Assets (Normalized) | 1.46% |
Return on Equity (Normalized) | 5.22% |
Return on Invested Capital (Normalized) | 6.32% |
Return on Assets
LMRI
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|>@DJt< | LOCK|sDh$< | $169B | |||
| Medtronic PLC
MDT
| LOCK|&<z!>v& | LOCK|&p<! | $110B | |||
| Stryker Corp
SYK
| LOCK|#z?YHj> | LOCK|$l | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|ZSQFs> | LOCK|#@xH | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|#<wt?#@ | LOCK|V^KL | $49B | |||
| DexCom Inc
DXCM
| LOCK|WwY?^%m | LOCK|St!l | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|k<?^n?$ | LOCK|$?Q | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|!vq | LOCK|km# | $23B | |||
| Steris PLC
STE
| LOCK|v%NYWB | LOCK|GDKj | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|!##HHfZ | LOCK|Qn | $17B |
United States